An algorithm can identify individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) with about 88% accuracy using electronic medical record (EMR) data, according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, held from Nov. 15 to 19 in San Diego.
AI algorithm can identify metabolic dysfunction-associated steatotic liver disease
